APA (7th ed.) Citation

Vu, T., Meisel, A., Mantegazza, R., Annane, D., Katsuno, M., Aguzzi, R., . . . Howard Jr., J. F. (2023). Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. Neurology & Therapy, 12(5), 1435. https://doi.org/10.1007/s40120-023-00514-4

Chicago Style (17th ed.) Citation

Vu, Tuan, et al. "Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis." Neurology & Therapy 12, no. 5 (2023): 1435. https://doi.org/10.1007/s40120-023-00514-4.

MLA (9th ed.) Citation

Vu, Tuan, et al. "Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis." Neurology & Therapy, vol. 12, no. 5, 2023, p. 1435, https://doi.org/10.1007/s40120-023-00514-4.